Skip to search boxSkip to navigationSkip to main content

MRI tracking of FePro labeled fresh and cryopreserved long term in vitro expanded human cord blood AC133+ endothelial progenitor cells in rat glioma

  • Branislava Janic(corresponding author)
    ,
  • Kourosh Jafari-Khouzani
    ,
  • Abbas Babajani-Feremi
    ,
  • A. S.M. Iskander
    ,
  • Nadimpalli Ravi S. Varma
    ,
  • Meser M. Ali
*Corresponding author for this work
  • Henry Ford Health System
    ,
  • Massachusetts General Hospital
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Background: Endothelial progenitors cells (EPCs) are important for the development of cell therapies for various diseases. However, the major obstacles in developing such therapies are low quantities of EPCs that can be generated from the patient and the lack of adequate non-invasive imaging approach for in vivo monitoring of transplanted cells. The objective of this project was to determine the ability of cord blood (CB) AC133+ EPCs to differentiate, in vitro and in vivo, toward mature endothelial cells (ECs) after long term in vitro expansion and cryopreservation and to use magnetic resonance imaging (MRI) to assess the in vivo migratory potential of ex vivo expanded and cryopreserved CB AC133+ EPCs in an orthotopic glioma rat model. Materials, Methods and Results: The primary CB AC133+ EPC culture contained mainly EPCs and long term in vitro conditions facilitated the maintenance of these cells in a state of commitment toward endothelial lineage. At days 15-20 and 25-30 of the primary culture, the cells were labeled with FePro and cryopreserved for a few weeks. Cryopreserved cells were thawed and in vitro differentiated or IV administered to glioma bearing rats. Different groups of rats also received long-term cultured, magnetically labeled fresh EPCs and both groups of animals underwent MRI 7 days after IV administration of EPCs. Fluorescent microscopy showed that in vitro differentiation of EPCs was not affected by FePro labeling and cryopreservation. MRI analysis demonstrated that in vivo accumulation of previously cryopreserved transplanted cells resulted in significantly higher R2 and R2* values indicating a higher rate of migration and incorporation into tumor neovascularization of previously cryopreserved CB AC133+ EPCs to glioma sites, compared to non-cryopreserved cells. Conclusion: Magnetically labeled CB EPCs can be in vitro expanded and cryopreserved for future use as MRI probes for monitoring the migration and incorporation to the sites of neovascularization.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

e37577

Journal (Volume, Issue Number)

PloS one (Volume 7, Issue 5)

Publication milestones

  • Published - 05/25/2012

Publication status

Published - 05/25/2012

ISSN

1932-6203

Publication IDs

  • Scopus: 84861475269
  • PubMed: 22662174

Publication metrics

Metrics

SciVal
citations
12
Scopus
citations
SciVal
FWCI
0.66
SciVal
Author count
8
SciVal
Paper percentile
69
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
18
Citation count
10

Funding Details

FunderFunding number
NINDS
R01NS055143